IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Completed · Not applicable
Conditions studied: Basal Cell Carcinoma, Chondrosarcoma
In brief
A treatment protocol that enables patients to have continued access to IPI-926.
Key facts
- Study ID
- NCT01609179
- Run by
- Infinity Pharmaceuticals, Inc.
- People needed
- 9
- Starts
- 2012-03-01
- Expected to finish
- 2012-11-01
- Last updated by the study team
- 2012-11-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Voluntarily sign the informed consent form
- Currently receiving IPI-926 while participating in an Infinity-sponsored IPI-926 study. Note: For blinded studies, patient's treatment assignment must be unblinded according to the instructions in the original protocol to confirm they are receiving IPI-926.
- Eastern Cooperative Oncology Group (ECOG) performance status: 0 or 1.
- Documented response or stable disease, as defined in the original protocol, at the time of entry to the extension study.
- Willingness and ability to continue IPI-926 dispensation and follow-up procedures at the current investigational site.
- Willingness and ability to comply with scheduled visits, treatment plans, and laboratory tests and other study procedures.
- Women of child-bearing potential (WCBP), defined as a sexually mature woman who has not undergone a hysterectomy or tubal ligation or who has not been naturally postmenopausal for at least 24 consecutive months, must have a negative serum or urine pregnancy test prior to treatment. All WCBP, all sexually active male patients, and all partners of patients must agree to use adequate methods of birth control throughout the study.
You may not qualify if…
- Discontinued IPI-926 or withdrew informed consent to participate in original Infinity-sponsored IPI-926 study.
- Require addition of or change to a new concomitant therapy to adequately treat the malignancy under study.
Where it is running
- University of Colorado Denver — Aurora, Colorado, United States
- Johns Hopkins — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.